3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma
3
Triple Negative Breast Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
1
Pancreatic Neoplasms
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Liver Neoplasms
1
Fibrolamellar hepatocellular carcinoma
1
Diabetes Mellitus, Insulin-Dependent, 12
1
Breast Neoplasms
1
Biliary Tract Neoplasms
1
Interventions
Oxaliplatin
10
Leucovorin
9
Fluorouracil
9
Specimen Handling
6
Cetuximab
6
Bevacizumab
6
Magnetic Resonance Spectroscopy
4
pembrolizumab
3
cemiplimab
3
Pemetrexed
3
fludarabine
2
dehydroftorafur
2
aldesleukin
2
Surveys and Questionnaires
2
Nivolumab
2
Irinotecan
2
Immunoglobulin G
2
Gemcitabine
2
Folfox protocol
2
Disulfides
2
Cyclophosphamide
2
Cisplatin
2
Carboplatin
2
Biopsy
2
ulixertinib
1
trifluridine tipiracil drug combination
1
trastuzumab deruxtecan
1
trastuzumab biosimilar HLX02
1
trametinib
1
tipiracil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Colonic Neoplasms
×
poly ICLC
×
30 days
×
Clear all
No trials found.